India remains on US trade "priority watch list" for failing to uphold international drug company patents.
作者信息
Arie Sophie
出版信息
BMJ. 2013 May 8;346:f2949. doi: 10.1136/bmj.f2949.
PMID:23657189
Abstract
摘要
相似文献
1
India remains on US trade "priority watch list" for failing to uphold international drug company patents.
BMJ. 2013 May 8;346:f2949. doi: 10.1136/bmj.f2949.
2
Biotech patents-business as usual?
Nat Biotechnol. 2008 Dec;26(12):1326. doi: 10.1038/nbt1208-1326.
3
Patent watch.
Nat Rev Drug Discov. 2013 Jan;12(1):14-5. doi: 10.1038/nrd3924.
4
Intellectual property. Challenges to India's pharmaceutical patent laws.
Science. 2012 Jul 27;337(6093):414-5. doi: 10.1126/science.1224892. Epub 2012 Jul 5.
5
US trade agreement threatens to increase drug prices and withhold safety data.
BMJ. 2013 Nov 15;347:f6908. doi: 10.1136/bmj.f6908.
6
Patents: a threat to innovation?
Science. 2010 Jan 1;327(5961):31-2; author reply 32. doi: 10.1126/science.327.5961.31.
7
Proposed trade agreement could increase patent protection for pharmaceuticals.
CMAJ. 2013 Jul 9;185(10):E459-60. doi: 10.1503/cmaj.109-4490. Epub 2013 May 21.
8
Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Conn J Int Law. 2002 Spring;17(2):157-248.
9
USA pressured to ease trade demands.
Lancet. 2004 Mar 6;363(9411):790. doi: 10.1016/S0140-6736(04)15723-1.
10
The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?
J Contemp Health Law Policy. 1996 Spring;12(2):607-36.
Zotero 插件